Day: February 23, 2022

Company’s partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatment WARSAW, Ind., Feb. 23, 2022 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced the 1,000th case performed with the FIREFLY® Pedicle Screw Navigation Guides (“FIREFLY”) technology in collaboration with Mighty Oak Medical. FIREFLY, which is frequently used in conjunction with OrthoPediatrics’ RESPONSE™ Spine System, provides increased efficiency by utilizing data-driven, pre-surgical planning for optimizing size and trajectory of the pedicle screws when performing complex spinal surgeries. The 3D printed patient-specific guides reduce the need for intraoperative...

NORWALK, Conn., Feb. 23, 2022 (GLOBE NEWSWIRE) — FactSet (NYSE:FDS) (NASDAQ:FDS) and BlackRock (NYSE:BLK) today announced that they have entered into a multi-year partnership to integrate Portware’s execution management system (EMS) capabilities with the Aladdin® platform, BlackRock’s end-to-end investment management and operations platform. The joint offering will provide common clients with a seamless experience across multi-asset portfolio and risk management, and trading execution, including access to Portware’s high-performance electronic trading and automation capabilities via API. FactSet’s Portware is best known in the listed assets and Foreign Exchange markets, and recently added fixed income trading capabilities; and the Aladdin® platform is leveraged by BlackRock and Aladdin clients to power informed decision-making...

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, is pleased to announce that it has appointed leading immunologist, Alexander Kharazi, M.D., Ph.D., to its Scientific Advisory Board. Dr. Kharazi co-invented Bria-IMT™, BriaCell’s lead clinical candidate, in collaboration with Dr. Charles L. Wiseman, BriaCell’s Founder and Principal Research Advisor. Dr. Kharazi currently serves as Chief Technology Officer at Stemedica Cell Technologies, Inc. His experience includes roles as Chief Scientist of the Immunotherapy laboratory at St. Vincent Medical Center in Los Angeles (1998-2006) and Chief Pathologist of a...

PHILADELPHIA, Feb. 23, 2022 (GLOBE NEWSWIRE) — AgroFresh Solutions, Inc. (Nasdaq: AGFS), a global leader in produce freshness solutions devoted to fighting food loss and waste, today announced that it will release fourth quarter and full year results after the market closes on Wednesday, March 09, 2022, followed by a conference call at 4:30 p.m. ET to discuss the results.   Conference Call The Company will host a conference call and webcast on Wednesday, March 09, 2022, at 4:30 p.m. ET where members of the executive management team will discuss fourth quarter results with additional comments and details. The conference call and supplemental earnings presentation will be available live over the internet through the “Events & Presentations” page of the Investor Relations section of the Company’s website at...

BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, announced today that it has signed a definitive agreement to acquire certain home health assets from AssistedCare Home Health, Inc., and RH Homecare Services, LLC, doing business as AssistedCare Home Health and AssistedCare of the Carolinas, respectively. Together, the companies care for more than 450 home health patients daily and employ approximately 100 employees in Leland and Snow Hill, North Carolina. The transaction is expected to close on or around April 1, 2022. While AssistedCare’s home health care services will transition to Amedisys Home Health, their personal care services will remain with Eldercare at Home, and their Intellectual & Developmental...

Victor M. Oviedo announced as new Chief Executive Officer of Investview. Eatontown, NJ, Feb. 23, 2022 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU) today announced that it has completed a restructuring of its executive management team with the appointment of a new slate of executive officers, including the appointment of Victor M. Oviedo as its new Chief Executive Officer. Mr. Oviedo has also been appointed to the Company’s Board of Directors. Mr. Oviedo brings a wealth of expertise to this role, having held several other key leadership roles throughout his 25-year career. For the past 4 years, Mr. Oviedo has been founder and managing partner of StageLight Group, which provides strategic capital to early and growth-stage companies. Prior to that, he was a Partner at SkyBridge Capital and Global Head of Business Development...

Best corrected visual acuity and central subfield thickness were significantly improved at 36 monthsILUVIEN treatment resulted in a 70.5% reduction in treatment burdenResults confirm that use of prior corticosteroid per the U.S. label mitigates the risk of IOP lowering surgeryATLANTA, Feb. 23, 2022 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that the 3-year results of the PALADIN study have been published in the peer-reviewed journal Ophthalmology. These study results show that patients with diabetic macular edema (DME) who received a single dose of the sustained release implant ILUVIEN (fluocinolone acetonide intravitreal...

New Capabilities Allow 22nd Century to Accelerate Revenue Streams and Create Higher Value Commercial Lines BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today, together with its global plant research partner KeyGene, a breakthrough in its hemp/cannabis plant research leading to the successful transformation of the hemp/cannabis plant genome using a proprietary plant transformation and regeneration technology and clear protein expression by the introduced genes. “I cannot emphasize enough what an enormous achievement it is for our company to have cracked the code to show proof of genome transformation in the hemp/cannabis...

FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that Enphase installers in New Jersey have seen a growing number of deployments of the Enphase® Energy System, powered by IQ™ Microinverters and IQ™ Batteries, as New Jersey residents seek protection against grid outages. Last year, tens of thousands of New Jersey residents experienced power outages following Hurricane Ida. These outages helped spur a growing interest in reliable backup power solutions like home solar and batteries. New Jersey residential storage capacity growth projections show steady year over year growth, with capacity expected to grow nearly 8-fold by 2026, according to the most recent...

Conference Call to be Held on March 8, 2022, at 5:00 PM (ET) NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced that it will release its earnings results for the Company’s fiscal first quarter 2022 on Tuesday, March 8, 2022, after market close. ABM will host its quarterly conference call for all interested parties on Tuesday, March 8, 2022, at 5:00 PM (ET). The live conference call can be accessed via audio webcast at the ‘Investors’ section of the Company’s website, located at www.abm.com, or by dialing (877) 451-6152 (domestic) or (412) 317-6671 (international) approximately 15 minutes prior to the scheduled time. A supplemental presentation will accompany the webcast on the Company’s website. A replay will be available approximately two hours after the webcast...